Mizuho Starts Tarsus Pharmaceuticals (TARS) at Outperform, 'Mite Be a Blockbuster: Bullish on Xdemvy'
Tweet Send to a Friend
(Updated - November 20, 2025 5:36 AM EST)
Mizuho analyst Graig initiates coverage on Tarsus Pharmaceuticals (NASDAQ: TARS) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Mizuho analyst Graig initiates coverage on Tarsus Pharmaceuticals (NASDAQ: TARS) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
